skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration
Collaborations are commonplace in HIV treatment trials and leverage expertise and experience of individual parties as researchers work toward ending this ongoing epidemic, but does study implementation slow down when too many parties are involved? In particular, is there any impact on recruitment rates when various sponsor types collaborate?

Highlights in this white paper include:

  • Enrollment Trends for All Trials, By Collaboration, and By Sponsor Type
  • Average Trial Enrollment Rate (TER) By Sponsor Type
  • Average Site Enrollment Rate (SER) and Number of Sites By Sponsor Type
  • Average Site Enrollment Rates (SERs) and Sites By Trial Size
  • Conclusion
     
Dec-2014_Collaborations-in-HIV-treatment-trials_Doro-Shin

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907
  • Japan            : +81 3-6273-4257

Or email us your inquiry, so we can provide you the best possible customer service:
pharma@informa.com

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: